Covid-19 Pandemic and Pancreatic Surgery in Italy (PanCOVID)
Effects of Covid-19 Pandemic on Pancreatic Surgery in Italy. A Multicenter Observational Clinical Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Lazio
-
Roma, Lazio, Italy, 00168
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS di Roma
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
all patients with a diagnosis of pancreatic cancer referred to one of the centers involved in the study during the two study periods
Exclusion Criteria:
- patients under the age of 18
- inability to give informed consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Pre-COVID
All patients with pancreatic cancer diagnosis before COVID-19 pandemic
|
Comparison between the pre-COVID and COVID groups of general, clinical, endoscopic and surgical outcomes
|
|
COVID
All patients with pancreatic cancer diagnosis during COVID-19 pandemic
|
Comparison between the pre-COVID and COVID groups of general, clinical, endoscopic and surgical outcomes
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in pancreatic cancer management during the COVID-19 pandemic
Time Frame: From admission to discharge/last outpatient visit, whichever comes first, assessed up to the 30th of June 2020
|
From admission to discharge/last outpatient visit, whichever comes first, assessed up to the 30th of June 2020
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Neoplasms
- Pneumonia, Viral
- Pneumonia
- Lung Diseases
- Neoplasms by Site
- Endocrine System Diseases
- Digestive System Neoplasms
- Endocrine Gland Neoplasms
- Pancreatic Diseases
- COVID-19
- Pancreatic Neoplasms
Other Study ID Numbers
Other Study ID Numbers
- FPGemelliIRCCS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.